Clinical validation of the new ELSA-CA 1
β
Maryvonne Clement; Paul Bischof; Claire Gruffat; Gabriel Ricolleau; Eliane Auvra
π
Article
π
1995
π
John Wiley and Sons
π
French
β 472 KB
The ELSA-CA 125 II is a second-generation radioimmunoassay for the quantification of CA I25 in serum. In a multicentre study involving 49 follow-ups of patients with ovarian cancers, and 880 other patients, 2.8% of healthy persons, 25% of 149 patients with benign gynaecological diseases and 39% of 8